dr. martin on subcutaneous administration of daratumumab in multiple myeloma
Published 4 years ago • 766 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
1:48
dr. usmani on subcutaneous delivery of daratumumab in myeloma
-
1:05
dr. harrison on subcutaneous daratumumab and isatuximab in myeloma
-
15:09
subcutaneous daratumumab — dr. jonathan kaufman | mcrt webcast july 11
-
2:43
dr. martin on treating first relapse in multiple myeloma
-
2:26
dr. martin on biomarker-driven therapeutics in multiple myeloma
-
1:47
practical management of iv daratumumab in mm
-
11:24
daratumumab in multiple myeloma
-
3:48
subcutaneous daratumumab in r/r myeloma: the columba trial
-
5:00
subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma
-
1:46
dr. martin on selinexor in triple-class refractory multiple myeloma
-
3:52
is dara being used in the frontline setting for myeloma patients?
-
4:59
columba: subcutaneous daratumumab vs. iv administration
-
3:24
does using daratumumab make response-monitoring difficult?
-
4:08
what is the latest on a new drug called selinexor?
-
0:52
dr. pecora on updated maia data in multiple myeloma
-
1:56
dr. kumar discusses study of ixazomib in multiple myeloma
-
2:59
pleiades: daratumumab combinations for multiple myeloma
-
3:05
sc daratumumab plus standard-of-care regimens in myeloma